Straits Times Index
3,256.61 +17.58 (+0.54%) Nikkei
27,513.47 +36.60 (+0.13%) Hang Seng
19,787.34 +219.65 (+1.12%) FTSE 100
7,471.77 +66.32 (+0.90%) Bitcoin USD
26,979.35 -714.10 (-2.58%) CMC Crypto 200
589.59 -17.86 (-2.94%)
INMD Jan 2024 120.000 call
- Motley Fool
Got $100? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
Teladoc specializes in virtual medical visits and sells its plans to companies and organizations. Teladoc also sells its BetterHelp mental health online consultations directly to consumers. What's weighed on the stock is the fact that Teladoc hasn't yet turned that revenue into profit.
- Motley Fool
2 Exceptional Growth Stocks That Could Jump 37.6% to 40.2% Higher, According to Wall Street
These businesses are at the top of their respective industries, but you wouldn't know it by looking at their stock prices.
- Motley Fool
Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential
The market doesn't always get a growth stock's valuation right, and when it's wrong, there's often an opportunity to make a hearty dollop of dosh -- and it's always good to feel as if you're a step ahead of the market. On that note, two growth stocks look favorably priced right now, and there's good reason to think they'll keep growing in the years ahead. Israeli medical aesthetics company InMode (NASDAQ: INMD) is a stellar investment opportunity thanks to its slightly cheap shares and its finely tuned growth engine.
